Invention Grant
US08017121B2 Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
失效
慢性类风湿关节炎治疗含有IL-6拮抗剂作为有效成分
- Patent Title: Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
- Patent Title (中): 慢性类风湿关节炎治疗含有IL-6拮抗剂作为有效成分
-
Application No.: US09756125Application Date: 2001-01-09
-
Publication No.: US08017121B2Publication Date: 2011-09-13
- Inventor: Tadamitsu Kishimoto , Masahiko Mihara , Yoichiro Moriya , Yoshiyuki Ohsugi
- Applicant: Tadamitsu Kishimoto , Masahiko Mihara , Yoichiro Moriya , Yoshiyuki Ohsugi
- Applicant Address: JP Tokyo JP Osaka
- Assignee: Chugai Seiyaku Kabushika Kaisha,Tadamistu Kishimoto
- Current Assignee: Chugai Seiyaku Kabushika Kaisha,Tadamistu Kishimoto
- Current Assignee Address: JP Tokyo JP Osaka
- Agency: Foley & Lardner LLP
- Priority: JP6-244035 19941007
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
There is provided a synovial cell growth inhibitor, or a pharmaceutical composition for treatment of chronic rheumatoid arthritis based on the synovial cell growth inhibitor.The pharmaceutical composition for treatment of chronic rheumatoid arthritis or synovial cell growth inhibitor contains an IL-6 antagonist, such as IL-6 antibody or IL-6R antibody, as an effective component.
Public/Granted literature
- US20010001663A1 Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component Public/Granted day:2001-05-24
Information query
